Monoclonal Antibodies in Cancer Therapy 单克隆抗体癌症治疗血管内皮生长因子抗肿瘤活性同位素标记放射性核素免疫系统免疫原性Yu-Ting GUO^pLaboratoryQin-Yu HOUofNan WANGIndustrial癌症生物学与医学(英文版)
Monoclonal antibodies target tumor-associated antigens in both solid and hematologic tumors. It is imperative that nurses be familiar with specific aspects of each antibody infusion they administer. 展开 关键词: Animals Humans Antibodies, Monoclonal Antigens, Neoplasm Immunity Protein Engineering Neoplasms...
Monoclonal antibody (MAb) therapy has emerged as an increasingly important modality in cancer therapy. Antibody-based therapeutics have shown efficacy alone and as components of effective therapies for an increasing number of human malignancies. Antibodies may mediate anti-tumor effects by employing a va...
Monoclonal antibodies and cancer therapy : Reisfeld, R.A. and Sell, S. (Eds.), 632 pp. Alan R. Liss, New York, 1985, $78.00, ISBN 0-8451-2626-1doi:10.1016/0022-1759(87)90090-1F. BorekElsevier B.V.Journal of Immunological Methods...
Monoclonal antibodies (mAbs) that regulate the immune response are now being clinically evaluated as anticancer agents. This Review discusses their progress to date and the possibilities for combining these antibodies with other cancer treatments. Increa
Monoclonal Antibody Therapy for Lymphoma Purpose: The purpose of this article is to review the historical development and recent advances in the application of monoclonal antibodies for the treatm... RO Dillman - 《Cancer Practice》 被引量: 106发表: 2001年 Current status of cancer therapy with...
Monoclonal antibody, antibody produced artificially through genetic engineering and related techniques. Production of monoclonal antibodies was one of the most important techniques of biotechnology to emerge during the last quarter of the 20th century.
Adverse events to monoclonal antibodies used for cancer therapy: Focus on hypersensitivity responses. OncoImmunology 2013; 2:e26333; http://dx.doi.org/10.4161/onci.26333 adverse events); and Type IV delayed mucocutaneous reactions as well as infusion reactions/cytokine release syndrome (IRs/CRS),...
, kidney, testis and colon. In humans, CD276 exists as two isoforms which result from gene duplication and differential splicing. CD276 is reported to have therapeutic potential for the regulation of cell-mediated immune responses to cancer, particularly in conjunction with anti-angiogenic therapy....
, kidney, testis and colon. In humans, CD276 exists as two isoforms which result from gene duplication and differential splicing. CD276 is reported to have therapeutic potential for the regulation of cell-mediated immune responses to cancer, particularly in conjunction with anti-angiogenic...